Stock Research for SNN

Featured Broker: Ally Invest

Get the due diligence for another stock.


SNN Stock Chart & Research Data

The SNN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SNN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


SNN Due diligence Resources & Stock Charts

The SNN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View SNN Detailed Price Forecast - CNN Money CNN View SNN Detailed Summary - Google Finance
Yahoo View SNN Detailed Summary - Yahoo! Finance Zacks View SNN Stock Research & Analysis -

Stock Analysis

TradeIdeas View SNN Trends & Analysis - Trade-Ideas Barrons View SNN Major Holders - Barrons
NASDAQ View SNN Call Transcripts - NASDAQ Seeking View SNN Breaking News & Analysis - Seeking Alpha
Spotlight View SNN Annual Report - OTC Report View SNN OTC Short Report -
TradeKing View SNN Fundamentals - TradeKing Charts View SNN SEC Filings - Bar Chart
WSJ View Historical Prices for SNN - The WSJ Morningstar View Performance/Total Return for SNN - Morningstar
MarketWatch View the Analyst Estimates for SNN - MarketWatch CNBC View the Earnings History for SNN - CNBC
StockMarketWatch View the SNN Earnings - StockMarketWatch MacroAxis View SNN Buy or Sell Recommendations - MacroAxis
Bullish View the SNN Bullish Patterns - American Bulls Short Pains View SNN Short Pain Metrics -

Social Media Mentions

StockTwits View SNN Stock Mentions - StockTwits PennyStocks View SNN Stock Mentions - PennyStockTweets
Twitter View SNN Stock Mentions - Twitter Invest Hub View SNN Investment Forum News - Investor Hub
Yahoo View SNN Stock Mentions - Yahoo! Message Board Seeking Alpha View SNN Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for SNN - Insider Cow View Insider Transactions for SNN - Insider Cow
CNBC View SNN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for SNN - OTC Markets
Yahoo View Insider Transactions for SNN - Yahoo! Finance NASDAQ View Institutional Holdings for SNN - NASDAQ

Stock Charts

FinViz View SNN Stock Insight & Charts - StockCharts View SNN Investment Charts -
BarChart View SNN Stock Overview & Charts - BarChart Trading View View SNN User Generated Charts - Trading View

Latest Financial News for SNN

Smith & Nephew plc (LON:SN.) Delivered A Better ROE Than The Industry, Here’s Why
Posted on Tuesday April 17, 2018

Smith & Nephew plc (LSE:SN.) delivered an ROE of 16.52% over the past 12 months, which is an impressive feat relative to its industry average of 10.23% during the sameRead More...

[$$] WPP Chairman Looks to Fill the Gap Left by Sorrell’s Sudden Exit
Posted on Monday April 16, 2018

A little known private-equity executive will steer WPP PLC through one of its stormiest periods following the resignation last weekend of Martin Sorrell.

Former Alere CEO named to head another medical device giant
Posted on Wednesday April 04, 2018

One of Massachusetts’ largest medical device employers, London-based Smith & Nephew, has named a new CEO who’ll be familiar to that company’s 1,100 Massachusetts employees.

Smith & Nephew picks new CEO who sold his last company
Posted on Wednesday April 04, 2018

Artificial hip and knee maker Smith & Nephew (SN.L), a perennial target of takeover speculation, said on Wednesday it had appointed a new chief executive with a track record of deal-making. Namal Nawana, who will replace Olivier Bohuon as CEO of the British company next month, most recently headed medical diagnostics firm Alere, where he oversaw its $5.3 billion sale to Abbott (ABT.N) in 2017. The medical technology firm, which also has wound-care and sports medicine units, is under pressure to improve margins and find new sources of growth as it competes with bigger rivals.

Enter a stock symbol to view the stock details.